Insider · CIK 0001216955
MARCUS JOEL S
Reports to the SEC for 9 companies · SOUTH SAN FRANCISCO, CA
Transactions
50
Companies
9
Filings
12
CIK
0001216955
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-13 | TRXBTRex Bio, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2026-10-13 | TRXBTRex Bio, Inc.C Conversion | — |
| 2026-10-08 | TRXBTRex Bio, Inc. · Stock Option (Right to Buy)A Award | — |
| 2026-09-11 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$248K |
| 2026-08-17 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$231K |
| 2026-05-06 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$164K |
| 2026-05-06 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$183K |
| 2026-05-05 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$86.4K |
| 2026-05-05 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$164K |
| 2026-05-05 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$70.2K |
| 2026-05-04 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$410K |
| 2026-02-12 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$418K |
| 2026-02-12 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.P Purchase | +$930K |
| 2026-01-23 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer | — |
| 2026-01-22 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer | — |
| 2026-01-09 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2026-01-02 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2025-04-02 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)D Disposition to Issuer | — |
| 2025-04-02 | Intra-Cellular Therapies, Inc.Restricted Stock UnitsD Disposition to Issuer | — |
| 2025-04-02 | Intra-Cellular Therapies, Inc.D Disposition to Issuer | −$6.37M |
| 2025-04-02 | Intra-Cellular Therapies, Inc.D Disposition to Issuer | −$1.32M |
| 2025-02-24 | Intra-Cellular Therapies, Inc.M Exercise/Conversion | +$447K |
| 2025-02-24 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2025-01-10 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2025-01-02 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2024-12-31 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer | — |
| 2024-06-23 | Intra-Cellular Therapies, Inc.Restricted Stock UnitsM Exercise/Conversion | — |
| 2024-06-23 | Intra-Cellular Therapies, Inc.M Exercise/Conversion | — |
| 2024-06-14 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award | — |
| 2024-06-14 | Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award | — |
| 2024-06-06 | APLTApplied Therapeutics, Inc.A Award | — |
| 2024-03-29 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.D Disposition to Issuer | — |
| 2024-03-29 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.F Tax Payment | −$696K |
| 2024-02-26 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.S Sale | −$892K |
| 2024-02-26 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-02-26 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)M Exercise/Conversion | — |
| 2024-02-26 | Intra-Cellular Therapies, Inc.M Exercise/Conversion | +$930K |
| 2024-02-26 | Intra-Cellular Therapies, Inc.S Sale | −$568K |
| 2024-02-26 | Intra-Cellular Therapies, Inc.S Sale | −$1.22M |
| 2024-02-26 | Intra-Cellular Therapies, Inc.M Exercise/Conversion | +$869K |
| 2024-02-26 | Intra-Cellular Therapies, Inc.S Sale | −$20.8K |
| 2024-01-10 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2024-01-05 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2024-01-02 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.A Award | — |
| 2023-09-15 | APLTApplied Therapeutics, Inc.M Exercise/Conversion | +$13K |
| 2023-09-15 | APLTApplied Therapeutics, Inc. · Employee Stock Option (Right to Buy)M Exercise/Conversion | — |
| 2023-06-23 | Intra-Cellular Therapies, Inc.Restricted Stock UnitsA Award | — |
| 2023-06-23 | Intra-Cellular Therapies, Inc.Stock Option (right to buy)A Award | — |
| 2023-06-06 | APLTApplied Therapeutics, Inc.A Award | — |
| 2023-05-08 | AREALEXANDRIA REAL ESTATE EQUITIES, INC.S Sale | −$917K |
Recent filings
- 4MARCUS JOEL S0001193125-26-420734SEC(opens sec.gov)
- 4MARCUS JOEL S0001193125-26-418302SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000021SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000019SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000017SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000015SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000013SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000011SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000009SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000007SEC(opens sec.gov)
- 4MARCUS JOEL S0001216955-26-000003SEC(opens sec.gov)
- 4MARCUS JOEL S0000950170-25-049596SEC(opens sec.gov)
Companies
- ALEXANDRIA REAL ESTATE EQUITIES, INC.Director, Executive ChairmanARE
- Applied Therapeutics, Inc.DirectorAPLT
- Atara Biotherapeutics, Inc.DirectorATRA
- Intra-Cellular Therapies, Inc.Director
- Korro Bio, Inc.DirectorKRRO
- MeiraGTx Holdings plcDirectorMGTX
- PennyMac Mortgage Investment TrustDirectorPMT
- Rexford Industrial Realty, Inc.DirectorREXR
- TRex Bio, Inc.DirectorTRXB
Address
C/O TREX BIO, INC. 269 EAST GRAND AVENUE, SUITE 300
SOUTH SAN FRANCISCO, CA, 94080